According to the latest market report published by Persistence Market Research titled Diabetic Foot Ulcer Therapeutics Market: Global Industry Analysis and Forecast (2016-2024), the global diabetic foot ulcer therapeutics market is expected to expand at a CAGR of 11.4% during the forecast period 20162024.
Get a Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/5441
Company Profiles:
B.Braun Melsungen AG
Smith & Nephew, Inc.
Organogenesis, Inc.
Derma Sciences Inc.
Sigvaris Inc.
3M
Acelity L.P. Inc.
Innocoll Holdings plc.
SIGVARIS, Inc.
Osiris
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/5441
Global Diabetic Foot Ulcer Therapeutics Market: Segmental Forecast
The global diabetic foot ulcer therapeutics market is segmented on the basis of product type, ulcer type, end user, and region.
On the basis of product type, the market has been segmented into advance wound dressings, skin substitutes, growth factors, and negative pressure wound therapy devices.
By ulcer type, the market has been segmented into neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers.
On the basis of end user, the market has been segmented into hospitals, specialty clinics, long-term care centers and ambulatory surgical centers. On the basis of region, the global diabetic foot ulcer therapeutics market has been segmented into five regions namely North America, Latin America, Europe, Asia Pacific and the Middle East & Africa.
By product type, the growth factors segment dominated the global diabetic foot ulcer therapeutics market in terms of revenue in 2016 and the trend is projected to continue throughout the forecast period.
The growth factors segment is the most attractive segment in the global diabetic foot ulcer therapeutics market, recording an attractiveness index of 1.8 and a CAGR of 20.7% over the forecast period.
By ulcer type, the neuro-ischemic ulcers segment is expected to remain the largest segment, registering a significant CAGR of 14.4% in terms of value over the forecast period. The neuropathic ulcers segment is expected to reach a market value in excess of US$ 3,500 Mn by 2024 end, registering a CAGR of 8.6% during 2016 2024.
By end user, the hospitals segment is projected to be the fastest growing segment during the forecast period. Revenue from the hospitals segment is anticipated to grow 2.4x by 2024 end as compared to that in 2016.
The specialty clinics segment is expected to be the second most lucrative segment in the global diabetic foot ulcer therapeutics market, registering an attractiveness index of 1.3 during the forecast period.
Global Diabetic Foot Ulcer Therapeutics Market: Regional Forecast
By region, the North America diabetic foot ulcer therapeutics market dominated the global diabetic foot ulcer therapeutics market in revenue terms in 2016 and the trend is projected to continue throughout the forecast period.
Revenue from the North America market is anticipated to increase at a CAGR of 10.8% over 20162024 to reach a market valuation of more than US$ 3,100 Mn by 2024. The Asia Pacific market is projected to be the second most lucrative market in the global diabetic foot ulcer therapeutics market, with a market attractiveness index of 1.5 during the forecast period.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/5441
Global Diabetic Foot Ulcer Therapeutics Market: Growth Drivers and Challenges
Rising prevalence of diabetes and subsequent increase in the incidence of diabetic foot ulcer is the key factor that is significantly responsible for positively impacting the global diabetic foot ulcer therapeutics market.
Also, increasing demand for accelerated wound healing and faster recovery therapeutics and growing acceptance of ingenious technologies and protocols to manage complex and hard-to-heal wounds is likely to fuel the growth of the global diabetic foot ulcer therapeutics market over the forecast period.
However, the high cost of diabetic foot ulcer treatment medications may hamper the demand and subsequently restrain the growth of the global diabetic foot ulcer therapeutics market.
The lack of awareness regarding specific treatment options in developing countries such as China and India coupled with patient ignorance towards treatment options and medications is also expected to hinder the growth of the global diabetic foot ulcer therapeutics market during the forecast period.
Access Related Reports-
Recombinant Cell Culture Supplements Market
The global recombinant cell culture supplements market size over the forecast period is projected to expand at a CAGR close to 7% through 2031.
Human Papillomavirus Testing Market
The global Human Papillomavirus testing market is expected to reach nearly US$ 1,130 Mn by the end of 2025, reflecting a CAGR of 7.6% over the forecast period (20172025).
Single-Use Bioprocess System Market
The global single use bioprocess systems market was valued at US$ 4.4 Bn in 2020 and is expected to exhibit a CAGR of close to 20% over the forecast period (2020 2030).
High Throughput Process Development Market
The global high throughput process development market is projected to exhibit a CAGR of 9% over the forecast period (2019 2029).
About us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact us:
Persistence Market Research
Address 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. +1-646-568-7751
USA-Canada Toll-free +1 800-961-0353
Sales sales@persistencemarketresearch.com
